“The global Anti-Reflux Devices Market is estimated at a high CAGR during the forecast period (2021-2028)”.
Anti-reflux devices tend to target patients with GERD (Gastroesophageal reflux disease) and mild gastroesophageal junction (GEJ) defects. These devices do not alter the anatomy of the esophagus, GEJ, or stomach so they should not be considered as alternatives to surgical fundoplication for patients with significant anatomic abnormalities, including large hiatal or paraesophageal hernias.
Download free sample: https://www.datamintelligence.com/download-sample/anti-reflux-devices-market
The increasing prevalence of gastroesophageal reflux disease (GERD) will drive the market
Gastroesophageal reflux disease (GERD) is a digestive disorder that affects the ring of muscle between the esophagus and stomach. This ring is called the lower esophageal sphincter(LES). And its symptom is generally heartburn. It is a common disease globally, increasing prevalence and consequently a more significant burden on the healthcare system. Traditionally, it is considered a disease of middle-aged and older people. Since risk factors for GERD affect a growing number of the adult population, concerns have been raised that increasingly younger people may develop GERD.
The surgery for GERD is known as antireflux surgery and it involves a procedure called fundoplication. The aim of fundoplication is to reinforce the LES to recreate the barrier that stops reflux from occurring. This is done by wrapping a portion of the stomach around the bottom of the esophagus to strengthen, augment, or recreate the LES valve. Antireflux operations in recent times are most often performed by using a minimally invasive surgical technique called laparoscopy. This technique utilizes a narrow tube-like camera and several long, thin operating instruments. The camera, instruments are inserted into the abdomen in the operating room through several tiny (less than 1 cm or ½ inch) incisions on the abdominal wall.GERD is one of the most common gastrointestinal disorders, with approximately 20% of adults in western culture. A systematic review by El-Serag et al. estimated the prevalence of GERD in the U.S. between 18.1% to 27.8%.
By Surgery Type
By End User
Ambulatory Surgical Centers
Middle East and Africa
The Anti-Reflux Devices Market is moderately competitive with the presence of local as well as global companies. Some prominent key players in this market are Olympus, Avantis Medical Systems, Mederi Therapeutics, Medigus, Torax Medical, EndoGastric Solutions, Merit Medical Systems, Inc., Medivators, Inc. Medsinglong Co Ltd., Guangzhou Medunion Technologies Co.ltd and Guangzhou Maya Medical Equipment.Co.ltd